Nucleic Acids Research, 2001, Vol. 29, No. 2 464-478
© 2001 Oxford University Press
Conserved stem–loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing
Laboratoire de Maturation des ARN et Enzymologie Moléculaire, UMR 7567 UHP-CNRS, Université Henri Poincaré Nancy 1, Boulevard des Aiguillettes, BP239, 54506 Vandoeuvre-lès-Nancy cedex, France and 1Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA
The HIV-1 transcript is alternatively spliced to over 30 different mRNAs. Whether RNA secondary structure can influence HIV-1 RNA alternative splicing has not previously been examined. Here we have determined the secondary structure of the HIV-1/BRU RNA segment, containing the alternative A3, A4a, A4b, A4c and A5 3' splice sites. Site A3, required for tat mRNA production, is contained in the terminal loop of a stem–loop structure (SLS2), which is highly conserved in HIV-1 and related SIVcpz strains. The exon splicing silencer (ESS2) acting on site A3 is located in a long irregular stem–loop structure (SLS3). Two SLS3 domains were protected by nuclear components under splicing condition assays. One contains the A4c branch points and a putative SR protein binding site. The other one is adjacent to ESS2. Unexpectedly, only the 3' A residue of ESS2 was protected. The suboptimal A3 polypyrimidine tract (PPT) is base paired. Using site-directed mutagenesis and transfection of a mini-HIV-1 cDNA into HeLa cells, we found that, in a wild-type PPT context, a mutation of the A3 downstream sequence that reinforced SLS2 stability decreased site A3 utilization. This was not the case with an optimized PPT. Hence, sequence and secondary structure of the PPT may cooperate in limiting site A3 utilization.
* To whom correspondence should be addressed. Tel: +33 3 83 91 20 91; Fax: +33 3 83 91 20 93; Email: christiane.branlant{at}maem.uhp-nancy.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Zychlinski, S. Erkelenz, V. Melhorn, C. Baum, H. Schaal, and J. Bohne Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure Nucleic Acids Res., October 23, 2009; (2009) gkp694v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Jablonski, E. Buratti, C. Stuani, and M. Caputi The Secondary Structure of the Human Immunodeficiency Virus Type 1 Transcript Modulates Viral Splicing and Infectivity J. Virol., August 15, 2008; 82(16): 8038 - 8050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. M. Abbink and B. Berkhout RNA Structure Modulates Splicing Efficiency at the Human Immunodeficiency Virus Type 1 Major Splice Donor J. Virol., March 15, 2008; 82(6): 3090 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Singh, R. N. Singh, and E. J. Androphy Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes Nucleic Acids Res., January 28, 2007; 35(2): 371 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hallay, N. Locker, L. Ayadi, D. Ropers, E. Guittet, and C. Branlant Biochemical and NMR Study on the Competition between Proteins SC35, SRp40, and Heterogeneous Nuclear Ribonucleoprotein A1 at the HIV-1 Tat Exon 2 Splicing Site J. Biol. Chem., December 1, 2006; 281(48): 37159 - 37174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Madsen and C. M. Stoltzfus An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication J. Virol., August 15, 2005; 79(16): 10478 - 10486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lian and H. R. Garner Evidence for the regulation of alternative splicing via complementary DNA sequence repeats Bioinformatics, April 15, 2005; 21(8): 1358 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Buratti and F. E. Baralle Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process Mol. Cell. Biol., December 15, 2004; 24(24): 10505 - 10514. [Full Text] [PDF]
|
|
|
|
 |
|
 J. CABELLO-VILLEGAS, K. E. GILES, A. M. SOTO, P. YU, A. MOUGIN, K. L. BEEMON, and Y.-X. WANG Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor RNA, September 1, 2004; 10(9): 1388 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ropers, L. Ayadi, R. Gattoni, S. Jacquenet, L. Damier, C. Branlant, and J. Stevenin Differential Effects of the SR Proteins 9G8, SC35, ASF/SF2, and SRp40 on the Utilization of the A1 to A5 Splicing Sites of HIV-1 RNA J. Biol. Chem., July 16, 2004; 279(29): 29963 - 29973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, A. F. Muro, M. Giombi, D. Gherbassi, A. Iaconcig, and F. E. Baralle RNA Folding Affects the Recruitment of SR Proteins by Mouse and Human Polypurinic Enhancer Elements in the Fibronectin EDA Exon Mol. Cell. Biol., February 1, 2004; 24(3): 1387 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Domsic, Y. Wang, A. Mayeda, A. R. Krainer, and C. M. Stoltzfus Human Immunodeficiency Virus Type 1 hnRNP A/B-Dependent Exonic Splicing Silencer ESSV Antagonizes Binding of U2AF65 to Viral Polypyrimidine Tracts Mol. Cell. Biol., December 1, 2003; 23(23): 8762 - 8772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Freund, C. Asang, S. Kammler, C. Konermann, J. Krummheuer, M. Hipp, I. Meyer, W. Gierling, S. Theiss, T. Preuss, et al. A novel approach to describe a U1 snRNA binding site Nucleic Acids Res., December 1, 2003; 31(23): 6963 - 6975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Muh, R. H. Hovhannisyan, and R. P. Carstens A Non-sequence-specific Double-stranded RNA Structural Element Regulates Splicing of Two Mutually Exclusive Exons of Fibroblast Growth Factor Receptor 2 (FGFR2) J. Biol. Chem., December 13, 2002; 277(51): 50143 - 50154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Roy, J.-S. Paquette, J.-F. Fortin, and M. J. Tremblay The Immunosuppressant Rapamycin Represses Human Immunodeficiency Virus Type 1 Replication Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3447 - 3455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Bilodeau, J. K. Domsic, A. Mayeda, A. R. Krainer, and C. M. Stoltzfus RNA Splicing at Human Immunodeficiency Virus Type 1 3' Splice Site A2 Is Regulated by Binding of hnRNP A/B Proteins to an Exonic Splicing Silencer Element J. Virol., September 15, 2001; 75(18): 8487 - 8497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jacquenet, A. Mereau, P. S. Bilodeau, L. Damier, C. M. Stoltzfus, and C. Branlant A Second Exon Splicing Silencer within Human Immunodeficiency Virus Type 1 tat Exon 2 Represses Splicing of Tat mRNA and Binds Protein hnRNP H J. Biol. Chem., October 26, 2001; 276(44): 40464 - 40475. [Abstract] [Full Text] [PDF]
|
|